HomeBusiness NewsNovo Nordisk's weight loss drug Wegovy slashes risk of serious heart events Business NewsFinance November 11, 2023 Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart events By John Wright Share FacebookTwitterPinterestWhatsApp - Advertisement - The findings could expand use of Wegovy and help Novo maintain its lead over Eli Lilly, whose competing weight-loss drug Zepbound was just approved in the U.S… Share FacebookTwitterPinterestWhatsApp John Wright - Advertisement - Stay Connected 16,985FansLike4,568FollowersFollow Must Read Business News UPenn President Liz Magill resigns following backlash over congressional antisemitism testimony Jennifer - December 9, 2023 Business News The No. 1 way to respond when your in-laws are rude to you, says Harvard-trained etiquette expert December 9, 2023 Business News These are the most exciting travel destinations for 2024, according to National Geographic December 9, 2023 Business News From head to heart to diet, AI is learning to make a map of elite athletes’ bodies December 9, 2023 Related News Business News UPenn President Liz Magill resigns following backlash over congressional antisemitism testimony December 9, 2023 Business News The No. 1 way to respond when your in-laws are rude to you, says Harvard-trained etiquette expert December 9, 2023 Business News These are the most exciting travel destinations for 2024, according to National Geographic December 9, 2023 Business News From head to heart to diet, AI is learning to make a map of elite athletes’ bodies December 9, 2023 Business News People are spending hundreds a month on dating apps as free versions turn ‘borderline unusable’ December 9, 2023 LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
